Motus GI Holdings stock trades at its 52-week high
Published on 09/25/2026 at 06:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Motus GI Holdings stock stood at USD 0.0002 on September 11, 2026, matching the companys 52-week high. The quote gives investors a precise view of the securitys current OTCQB trading level, while its market capitalization was USD 1,277.
Pure-Vu remains the core product
Motus GI Holdings develops the Pure-Vu System, a medical device designed to help clean a poorly prepared colon during colonoscopy procedures, according to the companys investor relations page. The system is intended to integrate with standard and slim colonoscopes while preserving established clinical workflows.
The company describes Pure-Vu as its flagship product and positions the device around two measurable clinical and economic goals: improving the quality of colonoscopy examinations and reducing the cost of incomplete or delayed procedures. These product characteristics distinguish Motus GI Holdings from a conventional pharmaceutical developer because its commercial opportunity depends on device adoption and procedure utilization.
Price meets the yearly high
The September 11, 2026 quote of USD 0.0002 equaled the reported 52-week high of USD 0.0002. That comparison places the latest quoted level at 100 percent of the yearly peak, although the same data also show a 52-week low of USD 0.0000.
Market capitalization stood at USD 1,277 on the same date, while shares outstanding were listed at 6.389 million. The relationship between those two figures and the quoted share price highlights how small changes in the displayed quotation can materially affect the companys stated equity value.
OTCQB profile and investor data
Motus GI Holdings is classified in healthcare and medical devices, and its trading symbol is MOTS. The company is based in Fort Lauderdale, Florida, and has subsidiaries in the United States and Israel, according to its investor relations materials.
The companys current public profile therefore combines a narrowly defined medical-device product with a very small quoted equity value. For investors assessing MOTS, the key numerical reference points are the USD 0.0002 share price, the USD 1,277 market capitalization, and the 6.389 million shares outstanding, all dated September 11, 2026.
Trading level stays measurable
Motus GI Holdings stock was quoted at USD 0.0002 on the OTCQB on September 11, 2026. The price matched the 52-week high of USD 0.0002, providing the clearest available comparison for the stock at that date.
Motus GI Holdings at a glance
- Company: Motus GI Holdings, Inc.
- Ticker: MOTS
- Trading venue: OTCQB
- Price as of September 11, 2026: USD 0.0002
- Market capitalization: USD 1,277 as of September 11, 2026
- 52-week range: USD 0.0000-0.0002 as of September 11, 2026
- Sector / Industry: Healthcare / Medical Devices
